LESLIE GROUNDS: Open Payments
NPI 1659931186 · AUBURN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,410 in 119 payments from 16 companies in 2025. Trend: 2023 $1,861 · 2024 $2,195 · 2025 $2,410
Food & beverage: $2,302Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 49 | $790 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 15 | $365 |
| Janssen Biotech, Inc. | 14 | $343 |
| Novartis Pharmaceuticals Corporation | 9 | $225 |
| Regeneron Healthcare Solutions, Inc. | 9 | $182 |
| Arcutis Biotherapeutics, Inc. | 2 | $136 |
| PFIZER INC. | 5 | $85 |
| Amgen Inc. | 4 | $82 |
| E.R. Squibb & Sons, L.L.C. | 3 | $47 |
| Galderma Laboratories, L.P. | 2 | $45 |
Products named: RINVOQ, TREMFYA, SKYRIZI, Winlevi, DUPIXENT, Zoryve, VRAYLAR, CIBINQO.
Industry payments across AL — which companies pay providers there.
